Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | AMGN | GILD | CELG | VRTX |
| Company | Biomarin Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 89.46 | 269.84 | 66.93 | 108.01 | 397.30 |
| High | 89.81 | 273.14 | 67.57 | 108.59 | 406.34 |
| Low | 88.89 | 269.84 | 66.74 | 107.27 | 396.00 |
| Last | 89.49 | 271.91 | 66.95 | 108.24 | 399.92 |
| Change | +0.86 | +2.98 | +0.19 | +0.11 | +5.64 |
| % Change | +0.97% | +1.11% | +0.28% | +0.10% | +1.43% |
| Volume | 1,257,300 | 2,165,700 | 5,622,300 | 191,230,496 | 1,393,800 |
| 20-Day Average Volume | 1,398,675 | 2,239,560 | 6,350,505 | 16,188,930 | 960,430 |
| Previous Close | 88.63 | 268.93 | 66.76 | 108.13 | 394.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 88.80 | 272.35 | 69.61 | 108.17 | 404.73 |
| 20-Day Raw Stochastic | 55.31% | 40.27% | 13.17% | 63.25% | 29.27% |
| 20-Day Relative Strength | 53.18% | 47.06% | 32.36% | 64.69% | 43.46% |
| Weighted Alpha | -4.66 | +10.54 | -20.99 | +46.30 | +15.75 |
| Today's Opinion | 8% Buy | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 24% Sell | 56% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 88% Sell | 8% Buy | 88% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.21% since 04/15/24 | +2.41% since 04/15/24 | -1.18% since 04/15/24 | -1.97% since 11/13/19 | +0.64% since 04/15/24 |
| Low | 88.29 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 391.01 on 04/18/24 |
| High | 91.78 on 04/16/24 | 273.14 on 04/22/24 | 67.89 on 04/16/24 | 110.53 on 11/14/19 | 406.34 on 04/22/24 |
| 1-Month | |||||
| %Chg | +5.12% since 03/22/24 | -1.54% since 03/22/24 | -7.80% since 03/22/24 | +5.14% since 10/18/19 | -3.79% since 03/22/24 |
| Low | 84.70 on 03/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 93.36 on 04/15/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -4.84% since 01/22/24 | -12.33% since 01/22/24 | -14.64% since 01/22/24 | +13.63% since 08/20/19 | -9.13% since 01/22/24 |
| Low | 83.44 on 03/15/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 94.51 on 01/23/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +8.99% since 10/20/23 | -2.47% since 10/20/23 | -13.95% since 10/20/23 | +14.14% since 05/20/19 | +10.52% since 10/20/23 |
| Low | 76.02 on 11/02/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 99.56 on 12/14/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,727,494 | 144,247,584 | 83,121,344 | 77,035,920 | 101,905,216 |
| Shares Outstanding, K | 188,734 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 2,419,230,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | 167,650,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 646,210,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | 20,380,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.31 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.49 on 02/22/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 04/24/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 72.06 | 14.09 | 9.85 | 10.99 | 29.28 |